ATE430199T1 - Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie - Google Patents

Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie

Info

Publication number
ATE430199T1
ATE430199T1 AT99903498T AT99903498T ATE430199T1 AT E430199 T1 ATE430199 T1 AT E430199T1 AT 99903498 T AT99903498 T AT 99903498T AT 99903498 T AT99903498 T AT 99903498T AT E430199 T1 ATE430199 T1 AT E430199T1
Authority
AT
Austria
Prior art keywords
ige
ige binding
binding
binding sites
protein
Prior art date
Application number
AT99903498T
Other languages
English (en)
Inventor
Gary Bannon
A Burks
Hugh Sampson
Cocknell Gael
M Helm Ricki
E King Wina
Seven Stanley J
S Shin David
Original Assignee
Univ Arkansas
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arkansas, Sinai School Medicine filed Critical Univ Arkansas
Application granted granted Critical
Publication of ATE430199T1 publication Critical patent/ATE430199T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99903498T 1998-01-31 1999-01-29 Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie ATE430199T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US7328398P 1998-01-31 1998-01-31
US7462498P 1998-02-13 1998-02-13
US7459098P 1998-02-13 1998-02-13
US7463398P 1998-02-13 1998-02-13
US14122098A 1998-08-27 1998-08-27
PCT/US1999/002031 WO1999038978A1 (en) 1998-01-31 1999-01-29 Methods and reagents for decreasing allergic reactions

Publications (1)

Publication Number Publication Date
ATE430199T1 true ATE430199T1 (de) 2009-05-15

Family

ID=27535962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99903498T ATE430199T1 (de) 1998-01-31 1999-01-29 Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie

Country Status (8)

Country Link
US (1) US7485708B2 (de)
EP (1) EP1051494B1 (de)
JP (1) JP2002501748A (de)
AT (1) ATE430199T1 (de)
AU (1) AU743647B2 (de)
CA (1) CA2319437C (de)
DE (1) DE69940805D1 (de)
WO (1) WO1999038978A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1332029C (zh) * 1998-03-16 2007-08-15 阿尔克-阿贝洛有限公司 突变的重组过敏原
US6686164B1 (en) 1998-10-30 2004-02-03 Novozymes A/S Low allergenic protein variants
CA2348938A1 (en) * 1998-10-30 2000-05-11 Novozymes A/S Low allergenic protein variants
US20020009452A1 (en) * 1999-02-10 2002-01-24 Michael Caplan Method for altering undesirable immune responses to polypeptides
AU3717600A (en) * 1999-03-02 2000-09-21 Board Of Trustees Of The University Of Arkansas, The Methods and reagents for decreasing clinical reaction to allergy
AU3865400A (en) * 1999-03-03 2000-09-21 Mount Sinai School Of Medicine Of The City University Of New York, The Animal model of allergies
US6943010B1 (en) 1999-11-19 2005-09-13 Hortense W. Dodo Down-regulation and silencing of allergen genes in transgenic peanut seeds
EP1235920A2 (de) * 1999-11-19 2002-09-04 Alabama A & M University Herabregulierung und abschaltung von allergenen genen in transgenen erdnusssamen
WO2001039799A2 (en) * 1999-12-06 2001-06-07 Panacea Pharmaceuticals, Llc. Passive desensitization
WO2001031989A2 (en) * 1999-12-09 2001-05-10 Novozymes A/S High throughput screening (hts) assays for protein variants with reduced antibody binding capacity
EP1254167A2 (de) 2000-01-06 2002-11-06 Monsanto Technology LLC Herstellung von deallergenisierten patatin proteinen und patatin permutein proteinen
GB0006437D0 (en) 2000-03-17 2000-05-10 Leuven Res & Dev Vzw Compounds for the modulation of allergen sensitivity by antigens sharing T cell epitopes with allergens
JP2004527450A (ja) * 2000-04-06 2004-09-09 シーア ファーマスーティカルズ エルエルシー 微生物送達システム
AU2001254620A1 (en) * 2000-04-28 2001-11-12 Novozymes A/S Lipolytic enzyme variant
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
NZ525820A (en) * 2000-11-16 2005-01-28 Alk Abello As Mutant allergens
WO2002074250A2 (en) * 2001-03-16 2002-09-26 Panacea Pharmaceuticals Methods and reagents for decreasing clinical reaction to allergy
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
DE60205907T2 (de) * 2002-09-27 2006-02-16 Biomay Produktions- Und Handels-Aktiengesellschaft Hypoallergene Impfstoffe gegen Allergie basierend auf Lieschgraspollenallergen Phl p 7
AU2005252268B2 (en) * 2004-06-10 2012-06-28 Aravax Pty Limited Novel immunointeractive molecules and uses thereof
WO2005121166A1 (en) * 2004-06-10 2005-12-22 Monash University Novel immunointeractive molecules and uses thereof
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
EP2243791A1 (de) 2009-03-03 2010-10-27 PLS-Design GmbH Klonierung und rekombinante Produktion von Wespengiftprotease und zugehörige Verwendungsverfahren
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
EP2664624A1 (de) 2012-05-15 2013-11-20 Biomay Ag Allergenvarianten
ES2897421T3 (es) 2012-10-30 2022-03-01 Aravax Pty Ltd Nuevas moléculas inmunoterapéuticas y usos de las mismas
CA2907915C (en) 2013-04-03 2023-03-07 Allertein Therapeutics, Llc Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
RU2689552C2 (ru) 2013-09-25 2019-05-28 Аравакс Пти Лтд Новая иммунотерапевтическая композиция и ее применения
CN104280555B (zh) * 2014-10-24 2017-09-26 江南大学 一种快速检测花生过敏原Ara h 2的胶体金试纸条及其制备方法
US9920100B2 (en) 2015-06-05 2018-03-20 The Chinese University Of Hong Kong Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy
CN109295250B (zh) * 2018-10-31 2022-03-22 四川华汉三创生物科技有限公司 一种食源性植物过敏原成分的检测试剂盒和方法
WO2020186190A2 (en) * 2019-03-13 2020-09-17 Psomagen, Inc. Epitope-based approach for allergy treatments and inhibitors for crohn's disease

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US569345A (en) * 1896-10-13 Albert p
US548972A (en) * 1895-10-29 Weed-cutter
US580862A (en) * 1897-04-20 Cloth computing and measuring machine
US576149A (en) * 1897-02-02 Gustavus a
SE337223B (de) 1967-05-23 1971-08-02 Pharmacia Ab
US3720760A (en) 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US4171299A (en) 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
US4469677A (en) 1980-02-19 1984-09-04 Michael J Gabriel Polypeptide active immunosuppressant fraction
US4338297A (en) 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction
EP0063810B1 (de) 1981-04-29 1986-03-05 Ciba-Geigy Ag Prüfmittel und Ausrüstung für immunologische Analysen
US4888170A (en) 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
SE8205908D0 (sv) 1982-10-18 1982-10-18 Pharmacia Diagnostics Ab Sett att bilda polymerskikt
US4849337A (en) 1983-01-31 1989-07-18 Minnesota Mining And Manufacturing Company Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
CA1260828A (en) 1983-07-04 1989-09-26 Masakazu Iwai Therapeutic and prophylactic agent for gastrointestinal ulcers
US4816449A (en) 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4579840A (en) 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4696915A (en) 1984-05-25 1987-09-29 Hoffmann-La Roche Inc. Parathymosin alpha
US5026545A (en) 1984-09-17 1991-06-25 Baxter International, Inc. Treatment of allergy and composition therefor
US4658022A (en) 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4900556A (en) 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
IL86583A0 (en) 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5843710A (en) 1987-07-07 1998-12-01 Biotech Australia Pty. Limited And Csiro Vaccines against animal parasitic nematodes
US5049390A (en) 1987-09-02 1991-09-17 Allergy Immuno Technologies, Inc. Liposome containing immunotherapy agents for treating IgE mediated allergies
US5449760A (en) 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5169933A (en) 1988-08-15 1992-12-08 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
AT393137B (de) 1988-10-14 1991-08-26 Biomay Biotech Prod Verfahren zum screenen einer expressions-cdna- klonbank zur auffindung von polynukleotiden
US5061790A (en) 1989-07-10 1991-10-29 Molecular Diagnostics, Inc. Oxidative denaturation of protein analytes
JP2787162B2 (ja) 1989-08-24 1998-08-13 フマキラー株式会社 精製ダニアレルゲン
US5328991A (en) 1989-11-03 1994-07-12 Immulogic Pharmaceutical Corp. Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes
CA2073045C (en) 1989-11-03 2007-05-22 Malcolm L. Gefter A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor
US5547669A (en) 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US5674980A (en) 1989-12-21 1997-10-07 Biogen Inc Fusion protein comprising tat-derived transport moiety
US5804604A (en) 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
JP3307636B2 (ja) 1990-01-31 2002-07-24 ボード オブ リージェンツ オブ ザ ユニバーシティ オブ オクラホマ 自己免疫疾患のためのアッセイおよび治療
US6897287B1 (en) 1990-01-31 2005-05-24 Oklahoma Medical Research Foundation Ro/SSA peptide reagents for diagnosis of autoantibodies
US5091318A (en) 1990-04-13 1992-02-25 Abbott Laboratories Binding of allergens to a solid phase
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
WO1992002621A2 (en) 1990-08-08 1992-02-20 Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. Allergens of alder pollen and applications thereof
AT401180B (de) 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
WO1992003551A1 (en) 1990-08-13 1992-03-05 Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. Birch pollen allergen p14 for diagnosis and therapy of allergic diseases
JP3139777B2 (ja) 1990-08-27 2001-03-05 フマキラー株式会社 組換えダニアレルゲン
WO1992011859A1 (en) 1991-01-08 1992-07-23 Immulogic Pharmaceutical Corporation Peptide-mediated hyposensitization of the human t cell response to dermatophagoides spp. (house dust mite)
US5219990A (en) 1991-01-28 1993-06-15 Biogen, Inc. Papillomavirus e2 trans-activation repressors
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US5350835A (en) 1991-11-05 1994-09-27 Board Of Regents, University Of Texas Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
JP3156237B2 (ja) 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
ATE187459T1 (de) 1992-04-13 1999-12-15 Oklahoma Med Res Found Methoden and reagentien zur diagnose von autoantikörpern
US5719064A (en) 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
AU5411594A (en) 1992-10-27 1994-05-24 Biomay Produktions- Und Handelsgesellschaft M.B.H. Molecule fragments (peptides) of the main allergens contained in the pollen of trees of the (fagales) order
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
DE69305313T3 (de) 1992-12-22 2001-06-21 Univ Cincinnati Cincinnati Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen
US5558869A (en) 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
DE69333985T2 (de) 1992-12-31 2006-11-23 Immulogic Pharmaceutical Corp., Waltham Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung
ATE162397T1 (de) 1993-02-12 1998-02-15 Mayo Foundation Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
JP3451572B2 (ja) 1993-03-04 2003-09-29 アサヒビール株式会社 改変したダニ主要アレルゲン及びその製造方法
JPH08509966A (ja) 1993-03-12 1996-10-22 イミュロジック ファーマスーティカル コーポレイション ライグラス花粉アレルゲンのｔ細胞エピトープ
US6849427B1 (en) 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
US5710126A (en) 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
AT401937B (de) 1993-04-01 1996-12-27 Biomay Prod & Handel Rekombinantes lieschgras pollen allergen phl p ii
US5830463A (en) 1993-07-07 1998-11-03 University Technology Corporation Yeast-based delivery vehicles
JP3350794B2 (ja) 1993-09-29 2002-11-25 アサヒビール株式会社 改変したダニ主要アレルゲン
JP2828391B2 (ja) 1993-10-29 1998-11-25 東燃株式会社 オリゴ糖を表面に有するリポソーム
US5449669A (en) 1993-11-10 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services IgE-binding epitopes of a major heat-stable crustacean allergen derived from shrimp
US5731157A (en) 1993-12-30 1998-03-24 The Procter And Gamble Company Two-site allergen immunoassay
US5968526A (en) 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
JPH07285875A (ja) 1994-04-19 1995-10-31 Mineo Hayazaki ノミアレルゲンの製造方法および該方法により製造されるノミアレルゲン
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
SE9402089D0 (sv) 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
EP0819763B1 (de) 1995-03-28 2004-11-17 Asahi Breweries, Ltd. Gentechnologisch hergestelltes milbenantigen und herstellungsverfahren
US5840307A (en) 1995-03-31 1998-11-24 Immulogic Pharmacuetical Corp. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
BE1009359A7 (fr) 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
US5869040A (en) 1995-06-07 1999-02-09 Biogen, Inc Gene therapy methods and compositions
US5820880A (en) 1995-06-07 1998-10-13 The United States Of America As Represented By The Secretary Of The Army Liposomal formulation
EP0845043B1 (de) 1995-07-28 2007-06-27 Marie Curie Cancer Care Transportproteine und deren verwendungen
WO1997024139A1 (en) 1995-12-29 1997-07-10 University Of Arkansas Peanut allergens and methods
US5955593A (en) 1996-09-09 1999-09-21 Washington University BH3 interacting domain death agonist
US6017735A (en) 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses
BE1011033A6 (fr) 1997-03-05 1999-04-06 Univ Bruxelles Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
DE19713001A1 (de) 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
US5989814A (en) 1997-04-01 1999-11-23 Reagents Of The University Of California Screening methods in eucaryotic cells
US5888760A (en) * 1997-04-10 1999-03-30 Dade Microscan Inc. Universal test systems and methods of use thereof for identifying multiple families of microorganisms
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
DE69738124T2 (de) 1997-05-08 2008-06-12 Amarnath Maitra Verfahren zur Herstellung von hochmonodisperser, Polymeren, hydrophiler Nanopartikel
US5891432A (en) 1997-07-29 1999-04-06 The Immune Response Corporation Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
SE9703531D0 (sv) 1997-09-30 1997-09-30 Rudolf Valenta Non-anaphlactic forms of allergens and their use
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
DK1219300T3 (da) * 2000-12-28 2007-03-05 Biomay Prod & Handel Behandling af allergi

Also Published As

Publication number Publication date
DE69940805D1 (de) 2009-06-10
WO1999038978A1 (en) 1999-08-05
US20030049237A1 (en) 2003-03-13
US7485708B2 (en) 2009-02-03
JP2002501748A (ja) 2002-01-22
AU2350599A (en) 1999-08-16
CA2319437C (en) 2009-06-16
AU743647B2 (en) 2002-01-31
EP1051494B1 (de) 2009-04-29
CA2319437A1 (en) 1999-08-05
EP1051494A1 (de) 2000-11-15

Similar Documents

Publication Publication Date Title
ATE430199T1 (de) Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
DE69633940D1 (de) Verfahren zur isolierung von zellen
WO1999029882A3 (en) Methods for altering the nutritional value of a plant protein, vegetative storage protein, vsp, by altering the amino acid content of proteins
EP1603949B8 (de) Antikörper gegen il21-rezeptor und deren verwendung
EP0670369A3 (de) An menschliches programmiertes Zelltod relatiertes Peptid, und dessen kodierende DNA
CA2204253A1 (en) Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
WO2000052154A3 (en) Methods and reagents for decreasing clinical reaction to allergy
ATE429448T1 (de) Peptidzusammensetzung als immunogen zur allergiebehandlung.
WO2002042427A3 (en) Mass tags for quantitative analysis
WO2001096373A3 (en) Fluorescent timer proteins and methods for their use
WO2003074004A3 (en) Method of producing antigens
Chamulitrat et al. Nitroxide metabolites from alkylhydroxylamines and N-hydroxyurea derivatives resulting from reductive inhibition of soybean lipoxygenase.
ATE327252T1 (de) Verfahren zur identifizierung modifizierter rekombinanter graminaenpollen-allergene
WO1995006728A3 (en) T cell epitopes of ryegrass pollen allergen
WO2002074250A3 (en) Methods and reagents for decreasing clinical reaction to allergy
DE60028248D1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
WO2004000217A3 (en) Vaccines for suppressing ige-mediated allergic disease and methods for using the same
ATE472337T1 (de) Pharmazeutische zusammensetzung aus f(ab) 2- fragmenten von antikörpern und verfahren zu ihrer herstellung
WO2003057821A3 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
DE3786673D1 (de) Verfahren zur entfernung unerwuenschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikoerper und dafuer geeigneter kit.
NO950526D0 (no) T-celleepitoper av raigresspollen-allergen
DE60100025D1 (de) Behandlung von Proteinen aus Gelen zur Analyse durch Verwendung von Massenspektrometrie
ATE339448T1 (de) Verfahren zur trennung von glykosylierten und nicht-glykosylierten proteinen
DE50010525D1 (de) Verfahren zur isolierung und aufreinigung von gräserpollenallergenen
ATE439368T1 (de) Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties